Skip to main content

+Dalethyne prevents nosocomial infection without antibiotics

Tinuku ~ Airlangga University students bring +Dalethyne as a nosocomial infection solution without antibiotics. Kayapan Satya Dharsha designing an active compound is expected to be a breakthrough to overcome the nosocomial infections that have become the biggest challenge of global health services.

Tinuku +Dalethyne prevents nosocomial infection without antibiotics

The 21st Meeting of the Indonesian Plastic Surgery Specialist Society in Yogyakarta conveys a discussion of +Dalethyne active substances that can be prevented nosocomial infection before, during and after medical intervention.

+Dalethyne is the exclusive active substance used in Dermazone MedCare products and is believed to kill germs that cause nosocomial infections are MRSA, ESBL, KPC and Pseudomonas aeruginosa.

Substance designed by Kayapan Satya Dharsha, an Airlangga University Student in Surabaya, is a breakthrough for surgical wound therapy without the consumption of antibiotics, but has the same advantages as antibiotics to control bacteria.

Dharsha and team worked more than a decade to create a machine to produce active substances. Dalet is four in Hebrew to symbolize the four main forces as an antiseptic, preventing antimicrobial resistance, eliminating scarring and accelerating skin proliferation.

"Currently we are continuing to research to maximize the use of +Dalethyne to prevent nosocomial infections and other major health care issues," Dharsha said in a press release on Friday, May 12, 2017.

The active substance has been tested in the UK, Japan and Malaysia. +Dalethyne has exclusively been used in PT Dermozone Pratama Indonesia product line for wound care and skin health. Throughout 2016, +Dalethyne at 50% concentration kills germs that cause nosocomial infections.

The ointment containing +Dalethyne is applied to the local wound immediately removes the odor and removes the pus in the surgical wound of squamous cell carcinoma in the penis at stage 4 without any antibiotic consumption.

WHO data noted that 10% of the world's patients with nosocomial infections are suffering in Southeast Asia. The problem is increasingly complicated the more rampant cases of microbial resistance causes 700,000 deaths each year.

A study predicts microbial resistance causes 10 million deaths annually by 2050 and spends US$10 trillion in prevention funds each year. Superbug has been found in the Intensive Care Unit (ICU) and 64% of cases of infections in the bloodstream and surgical wound.

Comments

Popular posts

GyroCycle motorcycle self-balancing gyroscope tech by Thrustcycle Enterprises LLC ready market 2017

Tinuku ~ Thrustcycle Enterprises LLC has been set up GyroCycle electric motorcycle that will not collapse even without the support for the production in 2017. The company is based in Honolulu designing electric motorcycles equipped gyroscopic technology for stability and anti-collapse.

Know Various Types of Traditional Indonesian Batik Patterns

Tinuku ~ Various types of batik spread across the archipelago. Batik is art of painting using cloth has a pattern and a special way of making the write or paste on the fabric. By treatment with certain distinctive ways.

Batik is pictorial cloth made specifically by writing or applying wax to cloth and since October 2, 2009 batik has been designated as one of Indonesia's cultural heritage by UNESCO.

Everyone knows batik designs have supernatural powers and each motif worn only by specific users. Parang motif which symbolizes strength and power, should only be worn by rulers and knights. Batik of this type must be made with calmness and patience.


If you do wrong in the batik process, the magical power is lost. The process of making batik is full of philosophical meaning, batik is a meaningful symbols that shows how society thinks maker.

Perhaps you just know only one kind of batik design. But geography and area of Indonesia storing various types of batik motifs depending on region t…

GlaxoSmithKline, Novartis AG and Bill Gates pushing against malaria

GlaxoSmithKline Plc and Novartis AG will donate a research fund of up to US$4 billion in a global effort to fight malaria as a drug-resistant strain has not progressed for years. Commitment is part of a broad initiative led by the Bill & Melinda Gates Foundation with US$1 billion,

Glaxo invested an additional US$250 million, while Novartis will allocate more than US$100 million, the company said before Wednesday's meeting in London. Urgency increases when the case of malaria grows significantly in 2016 for the first time in a decade. The emergence of resistance to drugs and insecticides makes efforts to eradicate the disease more difficult.


Certain variants of the lethal parasite Plasmodium falciparum are able to avoid artemisinin as the most potent drug available today. This resistant strain has been detected in five Asian countries and takes risks in Africa. Philanthropic billionaire Bill Gates has said it would be a "disaster" if the mutant form of the parasite mo…